Free Trial

Akoya Biosciences (AKYA) Competitors

Akoya Biosciences logo
$1.29 0.00 (0.00%)
As of 07/8/2025

AKYA vs. MASS, FEIM, KEQU, RPID, OWLT, SEER, OPXS, PRE, NAUT, and INTT

Should you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include 908 Devices (MASS), Frequency Electronics (FEIM), Kewaunee Scientific (KEQU), Rapid Micro Biosystems (RPID), Owlet (OWLT), Seer (SEER), Optex Systems (OPXS), Prenetics Global (PRE), Nautilus Biotechnology (NAUT), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.

Akoya Biosciences vs. Its Competitors

Akoya Biosciences (NASDAQ:AKYA) and 908 Devices (NASDAQ:MASS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

Akoya Biosciences has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akoya Biosciences$79.96M0.81-$55.37M-$0.97-1.33
908 Devices$59.63M4.46-$72.21M-$0.54-13.74

79.4% of Akoya Biosciences shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 7.3% of Akoya Biosciences shares are owned by company insiders. Comparatively, 23.7% of 908 Devices shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

908 Devices has a net margin of -28.80% compared to Akoya Biosciences' net margin of -59.44%. 908 Devices' return on equity of -27.10% beat Akoya Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Akoya Biosciences-59.44% -487.85% -35.86%
908 Devices -28.80%-27.10%-20.49%

Akoya Biosciences has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.

In the previous week, 908 Devices had 5 more articles in the media than Akoya Biosciences. MarketBeat recorded 6 mentions for 908 Devices and 1 mentions for Akoya Biosciences. 908 Devices' average media sentiment score of 1.34 beat Akoya Biosciences' score of 0.00 indicating that 908 Devices is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Akoya Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
908 Devices
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Akoya Biosciences currently has a consensus target price of $2.51, suggesting a potential upside of 94.26%. 908 Devices has a consensus target price of $5.33, suggesting a potential downside of 28.12%. Given Akoya Biosciences' higher probable upside, analysts clearly believe Akoya Biosciences is more favorable than 908 Devices.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Akoya Biosciences
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
908 Devices
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

908 Devices beats Akoya Biosciences on 11 of the 16 factors compared between the two stocks.

Get Akoya Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AKYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AKYA vs. The Competition

MetricAkoya BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$64.44M$3.06B$5.75B$9.55B
Dividend YieldN/A2.37%4.71%4.01%
P/E Ratio-1.338.0820.8516.92
Price / Sales0.81330.31461.42104.42
Price / CashN/A42.6036.1858.54
Price / Book8.608.328.655.87
Net Income-$55.37M-$55.19M$3.25B$258.89M
7 Day PerformanceN/A5.86%4.30%3.70%
1 Month Performance-3.01%17.29%10.57%11.71%
1 Year Performance-47.56%4.39%35.68%17.98%

Akoya Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AKYA
Akoya Biosciences
1.5279 of 5 stars
$1.29
flat
$2.51
+94.3%
N/A$64.44M$79.96M-1.3390
MASS
908 Devices
1.304 of 5 stars
$6.96
+3.9%
$5.33
-23.4%
+33.7%$240.27M$59.63M-12.8960News Coverage
FEIM
Frequency Electronics
1.5737 of 5 stars
$23.22
+8.2%
N/A+107.9%$207.76M$69.81M9.40200High Trading Volume
KEQU
Kewaunee Scientific
1.2602 of 5 stars
$57.77
+3.8%
N/A+8.8%$164M$240.47M15.081,239Positive News
RPID
Rapid Micro Biosystems
2.1389 of 5 stars
$3.40
-0.3%
$8.00
+135.3%
+495.6%$149.47M$28.05M-3.30200Upcoming Earnings
OWLT
Owlet
1.4314 of 5 stars
$7.74
-3.5%
$10.25
+32.4%
+105.8%$132.53M$78.10M-5.41106News Coverage
SEER
Seer
2.1076 of 5 stars
$2.13
+0.9%
$3.00
+40.8%
+6.8%$124.21M$14.17M-1.51160
OPXS
Optex Systems
1.9198 of 5 stars
$12.73
-8.9%
N/A+56.3%$96.57M$33.99M17.9380High Trading Volume
PRE
Prenetics Global
1.7596 of 5 stars
$8.07
+2.0%
$9.00
+11.5%
+39.2%$96.54M$30.62M-2.021High Trading Volume
NAUT
Nautilus Biotechnology
3.0765 of 5 stars
$0.73
+0.3%
$2.13
+192.3%
-73.7%$91.47MN/A-1.35130Positive News
Upcoming Earnings
INTT
inTEST
3.6187 of 5 stars
$7.30
-0.3%
$12.00
+64.4%
-27.5%$91.21M$127.50M31.74320News Coverage

Related Companies and Tools


This page (NASDAQ:AKYA) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners